The impact of evodiamine on human anaplastic thyroid cancer therapy-an in vitro and in vivo study
{{output}}
Thyroid cancer (TC) is the most common endocrine malignancy, with anaplastic thyroid cancer (ATC) being the most aggressive subtype. Evodiamine (EVO), a bioactive compound derived from Evodia rutaecarpa, possesses anti-inflammatory and anti-tumor properties, t... ...
